IL-17A is a central regulator of lung tumor growth

被引:17
作者
Reppert, Sarah [1 ]
Koch, Sonja [1 ]
Finotto, Susetta [1 ]
机构
[1] Univ Erlangen Nurnberg, Inst Mol Pneumol, Labs Cellular & Mol Lung Immunol, Erlangen, Germany
关键词
IL-17A; tumor; lung; T-bet; T-regulatory cells; T-BET; CANCER; INTERLEUKIN-17; CELLS;
D O I
10.4161/onci.19735
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a recent study we reported increased expression of IL-17A in the lung of patients with lung adenocarcinoma. Local blockade of IL-17A in the lung, in a model of lung cancer revealed enhanced anti-tumor immunity characterized by increased IFN gamma, a diminished T-regulatory cell number and reduced tumor growth.
引用
收藏
页码:783 / 785
页数:3
相关论文
共 8 条
[1]   Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells [J].
Chen, Xi ;
Xie, Qichao ;
Cheng, Xiaoming ;
Diao, Xinwei ;
Cheng, Yue ;
Liu, Jiankun ;
Xie, Wei ;
Chen, Zhengtang ;
Zhu, Bo .
CANCER SCIENCE, 2010, 101 (11) :2384-2390
[2]   Interferons, immunity and cancer immunoediting [J].
Dunn, Gavin P. ;
Koebel, Catherine M. ;
Schreiber, Robert D. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) :836-848
[3]   Transcriptional Regulation of T Helper 17 Cell Differentiation [J].
Hwang, Eun Sook .
YONSEI MEDICAL JOURNAL, 2010, 51 (04) :484-491
[4]   Functional Specialization of Interleukin-17 Family Members [J].
Iwakura, Yoichiro ;
Ishigame, Harumichi ;
Saijo, Shinobu ;
Nakae, Susumu .
IMMUNITY, 2011, 34 (02) :149-162
[5]   A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer [J].
Reppert, S. ;
Boross, I. ;
Koslowski, M. ;
Tuereci, O. ;
Koch, S. ;
Lehr, H. A. ;
Finotto, S. .
NATURE COMMUNICATIONS, 2011, 2
[6]   Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells [J].
Szabo, SJ ;
Sullivan, BM ;
Stemmann, C ;
Satoskar, AR ;
Sleckman, BP ;
Glimcher, LH .
SCIENCE, 2002, 295 (5553) :338-342
[7]  
TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO
[8]  
2-Y